Orbital Myositis as an Initial Presentation of Lyme Disease.

Neurology

From the Department of Neurology (G.M.B., A.M.E.), Department of Radiology (R.M.), and Department of Pathology (A.M.E.), State University of New York, Upstate Medical University, Syracuse.

Published: November 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662990PMC
http://dx.doi.org/10.1212/WNL.0000000000207742DOI Listing

Publication Analysis

Top Keywords

orbital myositis
4
myositis initial
4
initial presentation
4
presentation lyme
4
lyme disease
4
orbital
1
initial
1
presentation
1
lyme
1
disease
1

Similar Publications

[Research progress on the manifestations prevention and treatment of immune-related adverse events in the neuro-ophthalmic efferent system related to immune checkpoint inhibitors].

Zhonghua Yan Ke Za Zhi

January 2025

Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Ophthalmology, Beijing Key Laboratory of Ophthalmology & Visual Sciences, Beijing100730, China.

Immune checkpoint inhibitors (ICI), as a new type of targeted therapeutic drugs, have demonstrated durable efficacy in cancer treatment. However, some patients receiving ICI treatment may be affected by immune-related adverse events (irAE). Compared with irAE in skin tissues, gastrointestinal system, etc.

View Article and Find Full Text PDF

A 66-year-old woman presents with unilateral orbital inflammation of several years of evolution, initially classified as idiopathic orbital inflammatory disease (IOID) subtype myositis. She presented with pain, eyelid inflammation and significant elevation of intraocular pressure, as well as radiological signs of exophthalmos and superior rectus myositis. She was treated with corticosteroids, with partial response.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!